Monday, November 16, 2015

FDA Approves Potential Myeloma Game Changer

(MedPage Today) -- Daratumumab is first-ever monoclonal antibody therapy for multiple myeloma
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)